Document is current
Any future updates will be listed below
-
Authors
Walsh, Roddy https://orcid.org/0000-0001-5092-8825
Mazzarotto, Francesco
Whiffin, Nicola
Buchan, Rachel
Midwinter, William
Wilk, Alicja
Li, Nicholas
Felkin, Leanne
Ingold, Nathan
Govind, Risha
Ahmad, Mian
Mazaika, Erica
Allouba, Mona
Zhang, Xiaolei
de Marvao, Antonio
Day, Sharlene M.
Ashley, Euan
Colan, Steven D.
Michels, Michelle
Pereira, Alexandre C.
Jacoby, Daniel
Ho, Carolyn Y.
Thomson, Kate L.
Watkins, Hugh
Barton, Paul J. R.
Olivotto, Iacopo
Cook, Stuart A.
Ware, James S.
-
Funding
Funding for this research was provided by:
Wellcome Trust (107469/Z/15/Z)
British Heart Foundation (SP/10/10/28431)
Fondation Leducq (11 CVD-01)
UK Department of Health (HICF-R6-373)
Italian Ministry of Health (RF-2013-02356787, NET-2011-02347173)
- License Information
-
More Information
Article History
Received: 26 November 2018
Accepted: 14 January 2019
First Online: 29 January 2019
Ethics approval and consent to participate
: This study was based on previously published clinical genetics sequencing data from the OMGL and LMM laboratories. For the prospective HCM cohort from the Royal Brompton Hospital London, all patients provided written informed consent and the study was approved by the regional ethics committee. The research in this study conformed to the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
